These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33900629)

  • 1. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
    Temiz SA; Abdelmaksoud A; Dursun R; Vestita M
    Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629
    [No Abstract]   [Full Text] [Related]  

  • 2. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series.
    Russo R; Cozzani E; Micalizzi C; Parodi A
    Acta Derm Venereol; 2022 May; 102():adv00711. PubMed ID: 35229165
    [No Abstract]   [Full Text] [Related]  

  • 3. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees.
    Bassi A; Mazzatenta C; Sechi A; Cutrone M; Piccolo V
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e497-e498. PubMed ID: 35188988
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
    Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
    Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post SARS-CoV-2 Vaccine Chilblains-like Lesions.
    Mungmunpuntipantip R; Wiwanitkit V
    J Rheumatol; 2022 Jul; 49(7):859. PubMed ID: 35428717
    [No Abstract]   [Full Text] [Related]  

  • 7. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
    Poizeau F; Triquet L; Dupuy A
    Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
    [No Abstract]   [Full Text] [Related]  

  • 9. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions".
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Sep; 83(3):e233-e234. PubMed ID: 32446824
    [No Abstract]   [Full Text] [Related]  

  • 11. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 12. Chilblain and Acral Purpuric Lesions in COVID-19.
    Wiwanitkit V
    Actas Dermosifiliogr (Engl Ed); 2020 Sep; 111(7):627. PubMed ID: 32565054
    [No Abstract]   [Full Text] [Related]  

  • 13. Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.
    Blau K; Lehr S; Aschoff R; Al Gburi S; Brück N; Chapsa M; Schnabel A; Abraham S; Jöhrens K; Beissert S; Günther C
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e29-e31. PubMed ID: 36149533
    [No Abstract]   [Full Text] [Related]  

  • 14. Chilblain lesions after COVID-19 mRNA vaccine.
    Pileri A; Guglielmo A; Raone B; Patrizi A
    Br J Dermatol; 2021 Jul; 185(1):e3. PubMed ID: 33904168
    [No Abstract]   [Full Text] [Related]  

  • 15. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
    Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
    Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
    Mehta P; Bunker CB; Ciurtin C; Porter JC; Chambers RC; Papdopoulou C; Garthwaite H; Hillman T; Heightman M; Howell KJ; Eleftheriou D; Denton CP
    Lancet Infect Dis; 2021 Jul; 21(7):912. PubMed ID: 33705725
    [No Abstract]   [Full Text] [Related]  

  • 17. Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases.
    Romaní J; Baselga E; Mitjà O; Riera-Martí N; Garbayo P; Vicente A; Casals M; Fumadó V; Fortuny C; Calzado S
    Actas Dermosifiliogr (Engl Ed); 2020 Jun; 111(5):426-429. PubMed ID: 32402369
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
    Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
    JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chilblain-like acral dermatosis.
    Michelerio A; Vassallo C; Tomasini C
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1521-1523. PubMed ID: 34028985
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
    Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
    Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.